CAM
AIDX

Cresset Asset Management’s 20/20 Biolabs Inc AIDX Stock Holding History

Cresset Asset Management’s Portfolio AIDX Stock Details AIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$497K Buy
+264,368
New +$1.12M ﹤0.01% 1071

Other funds holding AIDX

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Cresset Asset Management's AIDX Position: Q1 2026 in Review

Cresset Asset Management opened a new position in 20/20 Biolabs Inc (AIDX) in Q1 2026: 264,368 shares worth $497K. The stake represents ﹤0.01% of the portfolio and ranks #1071 among its holdings.

7 funds tracked by Wall St. Rank hold AIDX as of Q1 2026.

  • Cresset Asset Management held 264,368 shares of 20/20 Biolabs Inc worth $497K as of Q1 2026.
  • 20/20 Biolabs Inc was a new Cresset Asset Management position in Q1 2026.
  • 20/20 Biolabs Inc made up ﹤0.01% of Cresset Asset Management's portfolio in Q1 2026, its #1071 holding.
  • 7 funds tracked by Wall St. Rank held 20/20 Biolabs Inc as of Q1 2026.

Based on Cresset Asset Management's 13F filing for Q1 2026, filed 15 May 2026.